Christian de Goede1, Wyatt W Yue2, Guanhua Yan3, Shyamala Ariyaratnam4, Kate E Chandler5, Laura Downes5, Nasaim Khan5, Meyyammai Mohan6, Martin Lowe3, Siddharth Banka7. 1. Department of Paediatric Neurology, Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; Faculty of Health and Medicine, Lancaster University, Lancaster, UK. 2. Structural Genomics Consortium, Old Road Campus Research Building, University of Oxford, Oxford, UK. 3. Faculty of Life Sciences, University of Manchester, UK. 4. Department of Community and Neurodevelopmental Paediatrics, Royal Blackburn Hospital, East Lancashire Hospital NHS Trust, Blackburn, UK. 5. Manchester Centre for Genomic Medicine, St. Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. 6. Department of Ophthalmology, Royal Blackburn Hospital, East Lancashire Hospital NHS Trust, Blackburn, UK. 7. Manchester Centre for Genomic Medicine, St. Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK. Electronic address: Siddharth.Banka@manchester.ac.uk.
Abstract
INTRODUCTION: Next Generation Sequencing (NGS) is a useful tool in diagnosis of rare disorders but the interpretation of data can be challenging in clinical settings. We present results of extended studies on a family of multiple members with global developmental delay and learning disability, where another research group postulated the underlying cause to be a homozygous RABL6 missense variant. METHODS AND RESULTS: Using data from the Exome Variant Server, we show that missense RABL6 variants are unlikely to cause early onset rare developmental disorder. Protein structural analysis, cellular functional studies and reverse phenotyping proved that the condition in this family is due to a homozygous INPP5E mutation. An in-depth review of mutational and phenotypic spectrum associated with INPP5E demonstrated that mutations in this gene lead to a range of cilliopathy-phenotypes. DISCUSSION: We use this study as an example to demonstrate the importance of careful clinical evaluation of multiple family members, reverse phenotyping, considering the unknown phenotypic variability of rare diseases, utilizing publically available genomic databases and conducting appropriate bioinformatics and functional studies while interpreting results from NGS in uncertain cases. We emphasize that interpretation of NGS data is an iterative process and its dynamic nature should be explained to patients and families. Our study shows that developmental delay, intellectual disability, hypotonia and ocular motor apraxia are common in INPP5E-related disorders and considerable intra-familial phenotypic variability is possible. We have compiled the INPP5E mutational spectrum and provided novel insights into their molecular mechanisms.
INTRODUCTION: Next Generation Sequencing (NGS) is a useful tool in diagnosis of rare disorders but the interpretation of data can be challenging in clinical settings. We present results of extended studies on a family of multiple members with global developmental delay and learning disability, where another research group postulated the underlying cause to be a homozygous RABL6 missense variant. METHODS AND RESULTS: Using data from the Exome Variant Server, we show that missense RABL6 variants are unlikely to cause early onset rare developmental disorder. Protein structural analysis, cellular functional studies and reverse phenotyping proved that the condition in this family is due to a homozygous INPP5E mutation. An in-depth review of mutational and phenotypic spectrum associated with INPP5E demonstrated that mutations in this gene lead to a range of cilliopathy-phenotypes. DISCUSSION: We use this study as an example to demonstrate the importance of careful clinical evaluation of multiple family members, reverse phenotyping, considering the unknown phenotypic variability of rare diseases, utilizing publically available genomic databases and conducting appropriate bioinformatics and functional studies while interpreting results from NGS in uncertain cases. We emphasize that interpretation of NGS data is an iterative process and its dynamic nature should be explained to patients and families. Our study shows that developmental delay, intellectual disability, hypotonia and ocular motor apraxia are common in INPP5E-related disorders and considerable intra-familial phenotypic variability is possible. We have compiled the INPP5E mutational spectrum and provided novel insights into their molecular mechanisms.
Authors: Sandra Jansen; Ilse M van der Werf; A Micheil Innes; Alexandra Afenjar; Pankaj B Agrawal; Ilse J Anderson; Paldeep S Atwal; Ellen van Binsbergen; Marie-José van den Boogaard; Lucia Castiglia; Zeynep H Coban-Akdemir; Anke van Dijck; Diane Doummar; Albertien M van Eerde; Anthonie J van Essen; Koen L van Gassen; Maria J Guillen Sacoto; Mieke M van Haelst; Ivan Iossifov; Jessica L Jackson; Elizabeth Judd; Charu Kaiwar; Boris Keren; Eric W Klee; Jolien S Klein Wassink-Ruiter; Marije E Meuwissen; Kristin G Monaghan; Sonja A de Munnik; Caroline Nava; Charlotte W Ockeloen; Rosa Pettinato; Hilary Racher; Tuula Rinne; Corrado Romano; Victoria R Sanders; Rhonda E Schnur; Eric J Smeets; Alexander P A Stegmann; Asbjørg Stray-Pedersen; David A Sweetser; Paulien A Terhal; Kristian Tveten; Grace E VanNoy; Petra F de Vries; Jessica L Waxler; Marcia Willing; Rolph Pfundt; Joris A Veltman; R Frank Kooy; Lisenka E L M Vissers; Bert B A de Vries Journal: Eur J Hum Genet Date: 2019-01-24 Impact factor: 4.246
Authors: Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries Journal: Eur J Hum Genet Date: 2017-12-05 Impact factor: 4.246
Authors: Steve Seltzsam; Chunyan Wang; Bixia Zheng; Nina Mann; Dervla M Connaughton; Chen-Han Wilfred Wu; Sophia Schneider; Luca Schierbaum; Franziska Kause; Caroline M Kolvenbach; Makiko Nakayama; Rufeng Dai; Isabel Ottlewski; Ronen Schneider; Konstantin Deutsch; Florian Buerger; Verena Klämbt; Youying Mao; Ana C Onuchic-Whitford; Camille Nicolas-Frank; Kirollos Yousef; Dalia Pantel; Ethan W Lai; Daanya Salmanullah; Amar J Majmundar; Stuart B Bauer; Nancy M Rodig; Michael J G Somers; Avram Z Traum; Deborah R Stein; Ankana Daga; Michelle A Baum; Ghaleb H Daouk; Velibor Tasic; Hazem S Awad; Loai A Eid; Sherif El Desoky; Mohammed Shalaby; Jameela A Kari; Hanan M Fathy; Neveen A Soliman; Shrikant M Mane; Shirlee Shril; Michael A Ferguson; Friedhelm Hildebrandt Journal: Genet Med Date: 2021-11-30 Impact factor: 8.864
Authors: Katherine L Helbig; Robert J Lauerer; Jacqueline C Bahr; Ivana A Souza; Candace T Myers; Betül Uysal; Niklas Schwarz; Maria A Gandini; Sun Huang; Boris Keren; Cyril Mignot; Alexandra Afenjar; Thierry Billette de Villemeur; Delphine Héron; Caroline Nava; Stéphanie Valence; Julien Buratti; Christina R Fagerberg; Kristina P Soerensen; Maria Kibaek; Erik-Jan Kamsteeg; David A Koolen; Boudewijn Gunning; H Jurgen Schelhaas; Michael C Kruer; Jordana Fox; Somayeh Bakhtiari; Randa Jarrar; Sergio Padilla-Lopez; Kristin Lindstrom; Sheng Chih Jin; Xue Zeng; Kaya Bilguvar; Antigone Papavasileiou; Qinghe Xing; Changlian Zhu; Katja Boysen; Filippo Vairo; Brendan C Lanpher; Eric W Klee; Jan-Mendelt Tillema; Eric T Payne; Margot A Cousin; Teresa M Kruisselbrink; Myra J Wick; Joshua Baker; Eric Haan; Nicholas Smith; Azita Sadeghpour; Erica E Davis; Nicholas Katsanis; Mark A Corbett; Alastair H MacLennan; Jozef Gecz; Saskia Biskup; Eva Goldmann; Lance H Rodan; Elizabeth Kichula; Eric Segal; Kelly E Jackson; Alexander Asamoah; David Dimmock; Julie McCarrier; Lorenzo D Botto; Francis Filloux; Tatiana Tvrdik; Gregory D Cascino; Sherry Klingerman; Catherine Neumann; Raymond Wang; Jessie C Jacobsen; Melinda A Nolan; Russell G Snell; Klaus Lehnert; Lynette G Sadleir; Britt-Marie Anderlid; Malin Kvarnung; Renzo Guerrini; Michael J Friez; Michael J Lyons; Jennifer Leonhard; Gabriel Kringlen; Kari Casas; Christelle M El Achkar; Lacey A Smith; Alexander Rotenberg; Annapurna Poduri; Alba Sanchis-Juan; Keren J Carss; Julia Rankin; Adam Zeman; F Lucy Raymond; Moira Blyth; Bronwyn Kerr; Karla Ruiz; Jill Urquhart; Imelda Hughes; Siddharth Banka; Ulrike B S Hedrich; Ingrid E Scheffer; Ingo Helbig; Gerald W Zamponi; Holger Lerche; Heather C Mefford Journal: Am J Hum Genet Date: 2018-10-18 Impact factor: 11.025
Authors: Isabel Hardee; Ariane Soldatos; Mariska Davids; Thierry Vilboux; Camilo Toro; Karen L David; Carlos R Ferreira; Michele Nehrebecky; Joseph Snow; Audrey Thurm; Theo Heller; Ellen F Macnamara; Meral Gunay-Aygun; Wadih M Zein; William A Gahl; May Christine V Malicdan Journal: Am J Med Genet A Date: 2017-10-20 Impact factor: 2.802
Authors: Riccardo Sangermano; Iris Deitch; Virginie G Peter; Rola Ba-Abbad; Emily M Place; Erin Zampaglione; Naomi E Wagner; Anne B Fulton; Luisa Coutinho-Santos; Boris Rosin; Vincent Dunet; Ala'a AlTalbishi; Eyal Banin; Ana Berta Sousa; Mariana Neves; Anna Larson; Mathieu Quinodoz; Michel Michaelides; Tamar Ben-Yosef; Eric A Pierce; Carlo Rivolta; Andrew R Webster; Gavin Arno; Dror Sharon; Rachel M Huckfeldt; Kinga M Bujakowska Journal: NPJ Genom Med Date: 2021-06-29 Impact factor: 8.617